{
    "meta": {
        "portal_name": "rare-diseases",
        "language": "en",
        "updated": "20150503"
    },
    "schema": {
        "html:portal": "http://en.recuweb.com/rare-diseases/",
        "graph:videos": "http://en.recuweb.com/graph/v1.0/rare-diseases/rare-diseases/videos.json",
        "graph:news": "http://en.recuweb.com/graph/v1.0/rare-diseases/rare-diseases/news.json",
        "graph:blogs": "http://en.recuweb.com/graph/v1.0/rare-diseases/rare-diseases/blogs.json"
    },
    "items": {
        "mideasttime.com/2015/05/acceleron-pharma-given-hold-rating-at-zacks-xlrn": {
            "title": "Acceleron Pharma Given Hold Rating at Zacks (XLRN)...",
            "snippet": "Zacks analyst wrote, Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge,...",
            "date": "2015-05-02",
            "categories": "cancer",
            "tags": "development,development-and-commercialization,commercialization,commercialization-of-protein,protein,protein-therapeutics,therapeutics,therapeutics-for-cancer,cancer,biopharmaceutical,biopharmaceutical-company,company,company-which-focuses,focuses,discovery,acceleron,acceleron_pharma,pharma,inc,analyst,analyst-wrote,wrote,zacks,xlrn,rare,diseases,cambridge",
            "recuweb_url": "http://en.recuweb.com/cancer/mideasttime.com/2015/05/acceleron-pharma-given-hold-rating-at-zacks-xlrn",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://mideasttime.com/acceleron-pharma-given-hold-rating-at-zacks-xlrn/430803/"
        },
        "wkrb13.com/2015/05/acceleron-pharma-rating-reiterated-by-zacks-xlrn": {
            "title": "Acceleron Pharma Rating Reiterated by Zacks (XLRN)...",
            "snippet": "Zacks analyst wrote, Acceleron Pharma Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. Acceleron Pharma Inc. is based in Cambridge,...",
            "date": "2015-05-02",
            "categories": "cancer",
            "tags": "development,development-and-commercialization,commercialization,commercialization-of-protein,protein,protein-therapeutics,therapeutics,therapeutics-for-cancer,cancer,biopharmaceutical,biopharmaceutical-company,company,company-which-focuses,focuses,discovery,analyst,analyst-wrote,wrote,acceleron,acceleron_pharma,pharma,zacks,xlrn,inc,rare,diseases,cambridge",
            "recuweb_url": "http://en.recuweb.com/cancer/wkrb13.com/2015/05/acceleron-pharma-rating-reiterated-by-zacks-xlrn",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://wkrb13.com/markets/578708/acceleron-pharma-rating-reiterated-by-zacks-xlrn/"
        },
        "fool.com/2015/05/could-this-dark-horse-be-pfizer-inc-s-next-major-acquisition": {
            "title": "Could This Dark Horse Be Pfizer Inc.'s Next Major Acquisition?",
            "snippet": "Pfizer is so ridiculously large... You may not even know it's a leader in area of rare diseases. When people think of Pfizer, I would bet dollars to doughnuts that drugs such as Viagra or Lipitor generally come to mind. And if you narrow the scope...",
            "date": "2015-05-02",
            "categories": "mind,drugs",
            "tags": "drugs,people,pfizer,inc,rare,diseases",
            "recuweb_url": "http://en.recuweb.com/drugs/fool.com/2015/05/could-this-dark-horse-be-pfizer-inc-s-next-major-acquisition",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://fool.com/investing/general/2015/05/02/could-this-dark-horse-be-pfizer-incs-next-major-ac.aspx"
        },
        "medpagetoday.com/2015/05/d-c-week-scotus-reignites-obamacare-contraception-debate": {
            "title": "D.C. Week: SCOTUS Reignites Obamacare Contraception Debate...",
            "snippet": "House Subcommittee Presses Forward on 21st Century Cures Roughly 95% of rare diseases have no FDA-approved treatment. Congress hopes that by equipping government agencies with better resources, it can accelerate innovation and bring cures to...",
            "date": "2015-05-02",
            "tags": "house,week,rare,diseases,congress",
            "recuweb_url": "http://en.recuweb.com/medpagetoday.com/2015/05/d-c-week-scotus-reignites-obamacare-contraception-debate",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://medpagetoday.com/Washington-Watch/Washington-Watch/51335"
        },
        "cityindex.co.uk/2015/05/pfizer-bidding-for-rare-disease-specialist-sobi": {
            "title": "Pfizer bidding for rare disease specialist Sobi...",
            "snippet": "Pfizer has established a Rare Disease Research Unit and sees drugs for rare diseases as an important opportunity in its mix of businesses, according to Reuters. Pfizer has actively been looking at takeover targets after a failed attempt to buy...",
            "date": "2015-05-02",
            "categories": "business,drugs",
            "tags": "targets,important,drugs,rare,disease,pfizer,specia,sobi,diseases,reuters",
            "recuweb_url": "http://en.recuweb.com/drugs/cityindex.co.uk/2015/05/pfizer-bidding-for-rare-disease-specialist-sobi",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://cityindex.co.uk/market-analysis/financial-news/us-stock-market-news/37513732015/pfizer-bidding-for-rare-disease-specialist-sobi/"
        },
        "bidnessetc.com/2015/05/shire-plc-adr-shpg-stock-rises-in-extended-trading-on-upbeat": {
            "title": "Shire PLC (ADR) (SHPG) Stock Rises In Extended Trading On Upbeat Results...",
            "snippet": "The company expanded its drug portfolio for rare diseases in February, when it went on to purchase NPS Pharmaceuticals Inc after a proposed sale of 52 billion to AbbVie Inc (NYSE:ABBV) fell apart. Shire is expected to continue buying smaller targets...",
            "date": "2015-05-02",
            "tags": "targets,inc,company,drug,rare,diseases",
            "recuweb_url": "http://en.recuweb.com/bidnessetc.com/2015/05/shire-plc-adr-shpg-stock-rises-in-extended-trading-on-upbeat",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://bidnessetc.com/41539-shire-plc-adr-shpg-stock-rises-in-extended-trading-on-upbeat-results/"
        },
        "homenewshere.com/2015/05/melchionda-ciaccio-team-up-to-run-marathon-and-raise-money": {
            "title": "Melchionda, Ciaccio team up to run marathon and raise money for rare diseases...",
            "snippet": "Danielle Ciaccio was at her in-laws, former long time Reading residents John and Linda Ciaccio, when her seventeen-month-old son Jackson suffered a massive ischemic stroke to the right side of his brain. While he was crawling, it was apparent he had...",
            "date": "2015-05-01",
            "categories": "stroke,marathon",
            "tags": "run,raise,rare,diseases",
            "recuweb_url": "http://en.recuweb.com/marathon/homenewshere.com/2015/05/melchionda-ciaccio-team-up-to-run-marathon-and-raise-money",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://homenewshere.com/daily_times_chronicle/news/reading/article_64bb90d6-f00b-11e4-a227-6b18dad28ad0.html"
        },
        "bleacherreport.com/2015/05/minnesota-vikings-mock-draft-updated-day-2-predictions": {
            "title": "Minnesota Vikings'Mock Draft: Updated Day 2 Predictions...",
            "snippet": "An excellent person off the field, Coates has won an award for making a positive impact in the fight against rare diseases. describes him as a genuine personality who won't get in trouble off the field. With that athletic package, however...",
            "date": "2015-05-01",
            "categories": "personality",
            "tags": "making,fight,person,rare,diseases",
            "recuweb_url": "http://en.recuweb.com/personality/bleacherreport.com/2015/05/minnesota-vikings-mock-draft-updated-day-2-predictions",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://bleacherreport.com/articles/2449697-minnesota-vikings-mock-draft-updated-day-2-predictions"
        },
        "nytimes.com/2015/05/speedy-drug-approvals-have-become-the-rule-not-exception": {
            "title": "Speedy Drug Approvals Have Become the Rule, Not the Exception...",
            "snippet": "Congress has over the past few decades passed a series of special approval pathways for important drugs that treat life-threatening or rare diseases. This week, a new bill introduced in the House could add two more. You might expect these existing...",
            "date": "2015-05-01",
            "categories": "drugs,life",
            "tags": "important,drugs,drug,congress,rare,diseases,week,house",
            "recuweb_url": "http://en.recuweb.com/life/nytimes.com/2015/05/speedy-drug-approvals-have-become-the-rule-not-exception",
            "resource_url": "http://www.bing.com/news/search?first=1&q=rare%2Bdiseases&format=RSS&cc=us",
            "source_url": "http://nytimes.com/2015/05/02/upshot/speedy-drug-approvals-have-become-the-rule-not-the-exception.html"
        },
        "reuters.com/2015/04/exclusive-pfizer-is-mystery-bidder-for-rare-disease-drugmaker-sobi-sources": {
            "title": "Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources - Reuters...",
            "snippet": "ReutersExclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sourcesReutersST), the rare disease specialist which disclosed this week that a potential buyer had made a preliminary offer, people with knowledge of the situation said.",
            "date": "2015-04-30",
            "tags": "people,week,pfizer,rare,disease,sobi,reuters,specia",
            "recuweb_url": "http://en.recuweb.com/reuters.com/2015/04/exclusive-pfizer-is-mystery-bidder-for-rare-disease-drugmaker-sobi-sources",
            "resource_url": "http://news.google.com/?hl=en&q=rare%2Bdiseases%2Brare%2Bdiseases&output=atom&nord=1",
            "source_url": "http://reuters.com/article/2015/04/30/us-sobi-pfizer-idUSKBN0NL1VQ20150430"
        }
    }
}